Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OSURthis companyOraSure Technologies, Inc.	$3.59	-2.57×	0.52×	1.55×	0.15×	-88.9%	41.9%	-59.2%	-59.8%	-20.2%	-18.6%	-0.0%	0.04×	3.28×	0×	6.58×	0.0%	4	3.11	2	B-
CATXPerspective Therapeutics, Inc.	$0.86	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
NAUTNautilus Biotechnolgy, Inc.	$2.35	-4.15×	1.57×	0×	-5.02×	-106.3%	0.0%	0.0%	0.0%	-37.6%	-35.7%	-21.1%	0.19×	-0.34×	0×	13.33×	0.0%	3	1.3	2	C
NTHINeonc Technologies Holdings, Inc.	$3.60	-2.56×	-9.07×	3,973.02×	-2.77×	-122.3%	100.0%	-145459.4%	-155404.4%	355.0%	519.7%	-13.1%	-0.36×	-0.1×	-23.23×	0.07×	0.0%	2	-66.25	2	C
STIMNeuronetics, Inc.	$2.27	-2.34×	4.07×	0.61×	-5.43×	-2342.1%	48.5%	-21.1%	-26.1%	-174.3%	-27.0%	-23.3%	4.04×	-2.07×	-3.74×	2.02×	0.0%	3	-3.35	2	C
TARAProtara Therapeutics, Inc.	$2.49	-3.98×	1.16×	0×	-3.19×	-57.1%	0.0%	0.0%	0.0%	-29.2%	-32.3%	-24.7%	0.02×	0.81×	0×	14.58×	0.0%	1	2.7	2	B-
Peer median	—	-2.56×	1.16×	0×	-3.19×	-106.3%	0.0%	0.0%	0.0%	-37.6%	-32.3%	-23.3%	0.02×	-0.1×	-3.74×	5.17×	0.0%	3	-0.5	2	—